Join the Health GAP Action Network

   CAMPAIGNS > ACTION ALERTS

 

 

 

HOME

HEALTH GAP

  • About HGAP
  • Accomplishments
  • Donate
  • FAQ
  • CAMPAIGNS

  • Bush AIDS Plan (PEPFAR)
  • Fund the GFATM
  • Patents & Medicine
  • U.S. Trade Agreements
  • Human Resources for Health
  • PRESS

  • Press Releases
  • In the News
  • Spokespeople
  • RESOURCES

  • HGAP Reports
  • Useful Links
  • CONTACT US

    SEARCH









    ACTION ALERTS

     

    04-Stop-AIDS Platform

      Endorse the platform AIDS activists will deliver to 2004 U.S. presidential candidates outlining demands for action.

      Download the 04-STOP-AIDS Platform here or Read Online.

      Send organizational endorsements to info@healthgap.org. Sorry, we are not compiling individual endorsements. Endorsing the platform does not mean endorsing or supporting a presidential candidate.


    BUSH, THE G8, AND RESOURCES FOR TREATMENT
      President Bush only wants to spend $2 million next year on global AIDS, mainly on his new AIDS plan. But programs that are up and running and saving lives now, like the Global Fund to Fight AIDS, Tuberculosis and Malaria, need full funding from the U.S. The Bush Administration has refused to give its fair share, and the Global Fund is facing bankruptcy as a result. Pres. Bush's AIDS plan is an important first step, but it won't be delivering real results for two more years--after 6 million more people have died of AIDS. We don't have time to waste waiting. We need $3 billion for global AIDS, including $1 billion for the Global Fund. $3 billion was already promised when Congress signed a global AIDS authorizing bill into law in spring.

      Go to campaign page and action alert to find out what you can do>>

    Go to campaign page >>

    TRADE POLICY AND HEALTH

      WTO talks collapse, but poor countries still have to contend with a flawed deal on generic medicines access WTO Members are still left with a complex and burdensome compromise agreement, bound in red tape. The WTO's next step is negotiating a permanent amendment to TRIPS about this issue, the 'paragraph 6' problem. Developing countries must fight for a permanent amendment that is workable, and makes it as easy for countries that are unable to do efficient local production to get generic versions of patented medicines as it is for the few rich countries who have sufficient local manufacturing capacity. The flawed text of the August 30 agreement does not provide this minimum assurance, and instead undermines the core principle of the Doha Declaration on TRIPS and public health, that countries should implement WTO intellectual property rules in a manner that supports public health and access to medicines for all.
    Go to campaign page >>

    SOUTH AFRICA: ACCESS TO TREATMENT

      From Treatment Action Campaign in South Africa:

      We cannot wait any longer for a visible and dynamic response from the government, business and international community. We do not need any more reports to tell us what we already know - HIV/AIDS is killing 600 people a day in this country and ruining lives and hopes. But with will and commitment this does not have to happen. With leadership from business and government, together with labour and communities, it is still possible to save lives and restore hope.

      TAC's Treatment Project will provide antiretroviral therapy to an equal number of TAC activists and community members. To find out more about the Project, and how you can help, go to: http://www.tac.org.za/treatment/
      Or download TAC's phamphlet: "We Need Your Help to Save Lives"

    • Health GAP letter to the South African gov't ( click here)
    TRADE POLICY AND HEALTH: THE AMERICAS
      The Free Trade of the Americas Agreement (FTAA) Threatens Access to Medicines in Latin America and the Caribbean Download a one-pager from Health GAP on the FTAA: PDF Document


    Back to Top

    HOME | HEALTH GAP | About HGAP | Accomplishments | Donate |CAMPAIGNS |Fund the GFATM |Patents & Medicine |U.S. Trade Agreements |Human Resources for Health |PRESS | Press Releases |In the News |Spokespeople | HGAP Reports |Useful Links | |CONTACT US |SEARCH